The Korean Journal of Parasitology (KJP)

Identification of novel anti‐leishmanials targeting glutathione synthetase of the parasite: a drug repurposing approach

Manash Sarma, Kushal Bora, Preeti Ranjan, Vikash Kumar Dubey

Molecular Mechanisms of Cell Death in Leishmania donovani Induced by Selected Steroidal Alkaloids

Naveena Menpadi, Pranjal Chandra, Vikash Kumar Dubey

Journal of Basic Microbiology.2025;[Epub] CrossRef

Key Facets for the Elimination of Vector-Borne Diseases Filariasis, Leishmaniasis, and Malaria

ACS Infectious Diseases.2025; 11(2): 287. CrossRef

Human migrations, anthropogenic changes, and insect-borne diseases in Latin America

André B. B. Wilke, Priscilla Farina, Marco Ajelli, Angelo Canale, Filipe Dantas-Torres, Domenico Otranto, Giovanni Benelli

Vaccines in Dermatology—Present and Future: A Review

Eyan Goh, Jean-Marc Chavatte, Raymond T. P. Lin, Lisa F. P. Ng, Laurent Rénia, Hazel H. Oon

Structure‐based Virtual Screening and Drug Design Development of Leishmanicidal Pyrimidines

Gerliny Bezerra de Oliveira, Érick Caique Santos Costa, Zenaide Severina do Monte, Gleybson Correia de Almeida, Emerson Peter da Silva Falcão, Luciana Scotti, Marcus Tullius Scotti, Ricardo Oliveira Silva, Daniele Santana de Sousa Oliveira, Policarpo Adem

Attitudes and acceptance of vaccination against neglected tropical diseases: A multi-country study in Asia

Li Ping Wong, Hai Yen Lee, Haridah Alias, Farhana Nishat Seheli, Abhishek Lachyan, Di Khanh Nguyen, Jamil Ahmed, Zhijian Hu, Yulan Lin

Human Vaccines & Immunotherapeutics.2025;[Epub] CrossRef

Vaccine Designing Technology against Leishmaniasis: Current Challenges and Implication

Jyoti Gupta, Yukta Menon, Subodh Kumar, Chakresh Kumar Jain

Current Drug Discovery Technologies.2025;[Epub] CrossRef

Cutaneous Leishmaniasis in the Context of Global Travel, Migration, Refugee Populations, and Humanitarian Crises

Janice Kim, Tarek Zieneldien, Sophia Ma, Bernard A. Cohen

Memory T cells: promising biomarkers for evaluating protection and vaccine efficacy against leishmaniasis

GSK-3 kinase a putative therapeutic target in trypanosomatid parasites

Alfredo Prado Diaz, Cristian Alejandro Meneses Canal, Alvaro José Valdés, Jaider Elian Giraldo Delgado, RE Varela-M

The Brazilian Journal of Infectious Diseases.2024; 28(2): 103736. CrossRef

Live attenuated-nonpathogenic Leishmania and DNA structures as promising vaccine platforms against leishmaniasis: innovations can make waves

Dual Antitubercular and Antileishmanial Profiles of Quinoxaline Di-N-Oxides Containing an Amino Acidic Side Chain

Juan F. González, María-Auxiliadora Dea-Ayuela, Lena Huck, José María Orduña, Francisco Bolás-Fernández, Elena de la Cuesta, Nazia Haseen, Ashraf Ali Mohammed, J. Carlos Menéndez

The role of CD4+ T cells in visceral leishmaniasis; new and emerging roles for NKG7 and TGFβ

Frontiers in Cellular and Infection Microbiology.2024;[Epub] CrossRef

Pilot-Scale Screening of Clinically Approved Drugs to Identify Uridine Insertion/Deletion RNA Editing Inhibitors in Trypanosoma brucei

Mojtaba Rostamighadi, Arezou Kamelshahroudi, Vanessa Pitsitikas, Kenneth A. Jacobson, Reza Salavati

ACS Infectious Diseases.2024; 10(9): 3289. CrossRef

Effect of Leishmania infantum infection on B cell lymphopoiesis and memory in the bone marrow and spleen

Laura Dirkx, Marlotte Loyens, Sara I. Van Acker, Dimitri Bulté, Mathieu Claes, Magdalena Radwanska, Stefan Magez, Guy Caljon

In silico and in vitro evaluation of the immunogenic potential of Leishmania donovani ascorbate peroxidase and its derived peptides

Shobha Kumari, Saravanan Vijaykumar, Vikash Kumar, Ravi Ranjan, Dayakar Alti, Veer Singh, Ghufran Ahmed, Ganesh Chandra Sahoo, Krishna Pandey, Ashish Kumar

The Major Role of T Regulatory Cells in the Efficiency of Vaccination in General and Immunocompromised Populations: A Review

Stanislaw Stepkowski, Dulat Bekbolsynov, Jared Oenick, Surina Brar, Beata Mierzejewska, Michael A. Rees, Obi Ekwenna

Prospects and Challenges of Genetically Modified Live-Attenuated Leishmania Vaccines

Suman Karmakar, Mousumi Das, Monalisa Ray, Soumyadip Mukherjee, Sanhita Ghosh, Kamalika Roy, Chiranjib Pal

A review of leishmaniasis: current knowledge and future directions of heterocyclic molecules

Exploration of Drug Science.2024; : 508. CrossRef

A squalene oil emulsified MPL-A and anti-CD200/CD300a antibodies adjuvanted whole-killed Leishmania vaccine provides durable immunity against L. donovani parasites

Baishakhi Mahapatra, Abhishek Singh, Arpita Banerjee, Shruti Sirohi, Samer Singh, Vikash K. Dubey, Rakesh K. Singh

C57BL/6 Peritoneal Macrophage Exosomes Improve Antileishmanial Functions of the RAW264.7 Cells

Hadis Gandomkar, Mostafa Changaei, Mir Mohammadreza Hosseini, Sara Soudi, Ahmad Zavaran Hosseini

India should invest in the expansion of genomic epidemiology for vector-borne diseases filariasis, malaria and visceral leishmaniasis that are targeted for elimination

Advances in Leishmania Vaccines: Current Development and Future Prospects

Andreina Ayala, Alejandro Llanes, Ricardo Lleonart, Carlos M. Restrepo

Development and application of species ID and insecticide resistance assays, for monitoring sand fly Leishmania vectors in the Mediterranean basin and in the Middle East

Sofia Balaska, Jahangir Khajehali, Konstantinos Mavridis, Mustafa Akiner, Kyriaki Maria Papapostolou, Latifa Remadi, Ilias Kioulos, Michail Miaoulis, Emmanouil Alexandros Fotakis, Alexandra Chaskopoulou, John Vontas, Yara M. Traub-Csekö

PLOS Neglected Tropical Diseases.2024; 18(12): e0012408. CrossRef

A Review of the Progress in the Development of Leishmaniasis Vaccines

Journal of Ardabil University of Medical Sciences.2024; 24(2): 129. CrossRef

A minor emphasis on the outbreak of cutaneous leishmaniasis after devastating earthquakes in Turkey

Asian Pacific Journal of Tropical Medicine.2023; 16(3): 97. CrossRef

Immunotherapy and immunochemotherapy in combating visceral leishmaniasis

Ganesh Yadagiri, Aakriti Singh, Kanika Arora, Shyam Lal Mudavath

Efficacy of an Immunotherapy Combining Immunogenic Chimeric Protein Plus Adjuvant and Amphotericin B against Murine Visceral Leishmaniasis

Danniele L. Vale, Camila S. Freitas, Vívian T. Martins, Gabriel J. L. Moreira, Amanda S. Machado, Fernanda F. Ramos, Isabela A. G. Pereira, Raquel S. Bandeira, Marcelo M. de Jesus, Grasiele S. V. Tavares, Fernanda Ludolf, Miguel A. Chávez-Fumagalli, Alexs

Evaluation of murine OX40L-murine IgG1(MM1) fusion protein on immunogenicity against L. mexicana infection in BALB/c mice

Hossein Rezvan, Selman A. Ali, Sahar Hamoon Navard, Robert Rees

Comparative Immunology, Microbiology and Infectious Diseases.2023; 99: 102011. CrossRef

Leishmania infection upregulates and engages host macrophage Argonaute 1, and system-wide proteomics reveals Argonaute 1-dependent host response

Atieh Moradimotlagh, Stella Chen, Sara Koohbor, Kyung-Mee Moon, Leonard J. Foster, Neil Reiner, Devki Nandan

Recent Patents in the Treatment and Prevention of Leishmaniasis

Pharmaceutical Patent Analyst.2023; 12(5): 237. CrossRef